Oct 22 | Apr 22 | Oct 21 | Apr 21 | Oct 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | £ 19.80M | £ 9.90M | £ 5.80M | £ 3.60M | £ 14.70M |
Total Assets | £ 620.10M | £ 596.20M | £ 531.50M | £ 509.30M | £ 541.40M |
Total Debt | £ 26.90M | £ 28.30M | £ 32.30M | £ 42.20M | £ 62.80M |
Net Debt | £ 7.10M | £ 18.40M | £ 26.50M | £ 38.60M | £ 48.10M |
Total Liabilities | £ 202.00M | £ 208.00M | £ 178.70M | £ 172.60M | £ 211.80M |
Stockholders Equity | £ 418.10M | £ 388.20M | £ 352.80M | £ 336.70M | £ 329.60M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |